Home › Cholesterol › Georgia
Cholesterol clinical trials in Georgia
4 studies for Cholesterol are looking for participants at sites in Georgia.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Northeast Georgia Heart Center, PC, Gainesville
- Atlanta Heart Specialists LLC, Tucker
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
- Research Site, Conyers
- Research Site, Decatur
- Research Site, Peachtree Corners
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT07619118A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Atlanta
- Research Site, Conyers
- Research Site, Decatur
- and 2 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- East Coast Research, Canton
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.